AL Amyloidosis Market
May 13, 2022
Assessing How Emerging Therapies Will Transform the AL Amyloidosis Treatment Dynamics
AL Amyloidosis is a rare disease, with around 8,500 new cases diagnosed each year in the 7MM. This disease mostly affects elderly persons median age of 64, with slight male predominance (54%). As per our estimates, the highest AL Amyloidosis incidence was observed in the US in 2021. Moreover, there are more than 30...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
